Training & Education

The Case CCC training effort is coordinated by Mark Jackson, PhD, Associate Director for Training and Education. The education effort comprises training of medical students, graduate students and postdoctoral students, and clinical and research training of residents and clinical fellows.

Mentored Training Programs

Clinical Oncology Research Career Development Program (CORP)
National Cancer Institute (NCI) K12 grant focused on interdisciplinary training in clinical and translational oncology therapeutic research.

Cancer Biology Training Grant
NCI T32 grant focused on interdisciplinary and collaborative research directly relevant to cancer.

Training in Computational Genomic Epidemiology of Cancer (CoGEC)
NCI R25 grant focused on transdisciplinary training at the intersection of cancer research, epidemiology, biostatistics, genetics, and computer science.

Cancer-focused Summer Undergraduate Research (CanSUR)
The goal of the program is to generate excitement for a future career in cancer research in highly motivated undergraduates and help them prepare for the next stage of their careers.

Cancer Biology Training Program
PhD training program developed as an interdisciplinary track within the Department of Pathology, and jointly sponsored by the Case CCC and the Department of Pathology. The program focus is on cancer research and includes the many facets of cancer biology, from basic science research to clinical and translational research.

Cancer Pharmacology Training Program
Multidisciplinary program designed for doctoral students and postdoctoral fellows who intend to pursue cancer research careers in a variety of basic or clinical science disciplines.

Cancer Center Summer Training for Medical Students

The Case Comprehensive Cancer Center supports medical students interested in summer research opportunities. There are limited openings available, with an equal number supported by the Brian Werbel Memorial Fund sponsored through University Hospitals Seidman Cancer Center and the Case Comprehensive Cancer Center. A call for applications is now open.